Triple-negative breast cancer (TNBC), as defined by the absence of estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor 2 (HER2) expression, corresponds to 10%–20% of all breast cancers [1]. The gene discussed is ESR1; the disease is triple-negative breast carcinoma.